Allenex AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Allenex AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10802
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Allenex AB (Allenex), formerly LinkMed AB, a subsidiary of CareDx Inc, is a blood stemcells and organs transplantation service provider. The company offers olerup SSP and absorber. Its oleruu is used before the transplantation. Allenex offers pre transplantation, transplantation and post transplantation services. The company offers screening, matching, testing, cleaning process, surgery, organ and blood management, medication, testing and follow up, and monitoring. It provides Reserch and development, production and quality assurance serves. The company serves hospitals, medical centers, and laboratories. The company operates in U.S. and Western Europe. Allenex is headquartered in Stockholm, Sweden.

Allenex AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allenex AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Allenex AB, Medical Devices Deals, 2012 to YTD 2018 9
Allenex AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Allenex AB, Pharmaceuticals & Healthcare, Deal Details 11
Acquisition 11
CareDx Acquires Allenex for up to USD34.1 Million 11
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 13
Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 14
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 15
Allenex Sells Stake In Pharmacolog i Uppsala For US$0.04 Million 16
Allenex AB – Key Competitors 17
Allenex AB – Key Employees 18
Allenex AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Allenex AB, Pharmaceuticals & Healthcare, Key Facts 2
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allenex AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allenex AB, Deals By Therapy Area, 2012 to YTD 2018 8
Allenex AB, Medical Devices Deals, 2012 to YTD 2018 9
Allenex AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CareDx Acquires Allenex for up to USD34.1 Million 11
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 13
Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 14
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 15
Allenex Sells Stake In Pharmacolog i Uppsala For US$0.04 Million 16
Allenex AB, Key Competitors 17
Allenex AB, Key Employees 18
Allenex AB, Subsidiaries 19

List of Figures
Allenex AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allenex AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Allenex AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Allenex AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Hagoromo Foods Corporation:企業の戦略・SWOT・財務情報
    Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PT Kimia Farma (Persero) Tbk (KAEF):企業の財務・戦略的SWOT分析
    PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Gene Techno Science Co Ltd (4584):企業の財務・戦略的SWOT分析
    Summary Gene Techno Science Co Ltd (GTS) develops and markets drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological, biosimilar and regenerative medicine in the therapy areas of renal disease, immunological, oncology, ophthalmic, and bone related di …
  • Dundee Precious Metals Inc.:企業の戦略・SWOT・財務情報
    Dundee Precious Metals Inc. - Strategy, SWOT and Corporate Finance Report Summary Dundee Precious Metals Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sanochemia Pharmazeutika AG (SAC)-医療機器分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Hindustan Construction Co Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MarkWest Energy Partners LP:企業のM&A・事業提携・投資動向
    MarkWest Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MarkWest Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Genisphere LLC-製薬・医療分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • Rice University-製薬・医療分野:企業M&A・提携分析
    Summary Rice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, mi …
  • Shelby Energy Cooperative, Inc.:企業の戦略的SWOT分析
    Shelby Energy Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Revolution Medicines Inc-製薬・医療分野:企業M&A・提携分析
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug discovery company with focus on the development of therapies for cancer. The company’s programs include SHP2 Program and mTOR Program. Its REVBLOCKS platform, an integrated suite of modular synthesis methodologies, facilitates the pro …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Reliance Communications Limited:企業の戦略・SWOT・財務分析
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Raysearch Laboratories AB (RAY B):企業の財務・戦略的SWOT分析
    Summary RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raystation and raycare. Its services include installation, support, training and training schedule. …
  • PureCircle Ltd:企業の戦略・SWOT・財務情報
    PureCircle Ltd - Strategy, SWOT and Corporate Finance Report Summary PureCircle Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆